Taxotere® Chemotherapy Permanent Hair Loss Lawsuits

Breast cancer is the most commonly diagnosed cancer among American women. After a diagnosis, a majority of patients undergo chemotherapy treatment, which often includes Taxotere®, an injectable concentrate. While patients are told to expect hair loss as a common side effect of treatment, some cancer survivors who were treated with Taxotere are experiencing a consequence they weren’t warned about—permanent significant alopecia.

If you or your mother, sister, daughter, or loved one were diagnosed with Stage 1, 2, or 3 cancers after 2005 and suffered permanent hair loss after chemotherapy treatment, contact Ferrer, Poirot & Wansbrough now.

Our Taxotere attorneys know the difficulties cancer survivors face to get to remission, and we understand the significant impact that permanent alopecia can have on self-esteem, body image, and quality of life after cancer treatment. Our law firm is here to help you stand up to the drug company. Talk to us today—call 24/7 at (800) 210-8503 or complete our free initial consultation form for a case review from our experienced lawyers.

Taxotere® Linked to Permanent Alopecia in Women

Hair loss during chemotherapy can be one of the most distressing side effects that cancer patients face—but it’s also well-documented and most often temporary. Complete hair regrowth usually occurs within 3-6 months after the completion of chemotherapy. However, since the mid-2000s, an increasing number of cancer survivors have reported permanent hair loss.

A study of twenty female breast cancer patients published in Annals of Oncology suggests that taxane chemotherapy drugs, including Taxotere, “seem to be responsible for [severe and permanent female hair loss].” Iron and zinc deficiencies were ruled out among study participants, and laboratory results showed that excessive androgen (a common cause of female hair loss) was also not a factor.

FDA Orders Taxotere® Warning Label Update

In December 2015, the United States Food and Drug Administration ordered Taxotere’s manufacturer to update drug labeling to include permanent alopecia as a potential drug reaction.

Taxotere® Permanent Alopecia Lawsuits

Surviving breast cancer is one of the most difficult moments any woman can go through in her lifetime. For patients in remission after successful chemotherapy treatment, significant permanent alopecia can have a lasting psychological impact long after treatment ends. We want to help.

At Ferrer, Poirot & Wansbrough, our drug injury lawyers have fought for the rights of drug injury victims for more than 30 years. Let us help you get the compensation you deserve if you’ve suffered permanent hair loss after taking Taxotere. Call (800) 210-8503 or complete our free initial consultation form now.

Taxotere® is a registered trademark of sanofi-aventis U.S. LLC and is used here only to identify the product in question. This law firm is not associated with, sponsored by, or affiliated with Annals of Oncology, sanofi-aventis U.S. LLC, or the U.S. Food and Drug Administration.